首页> 外国专利> PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING A MICROORGANISM INFECTION DISEASE COMPRISING A CHEMICAL COMPOUND WITH AN INHIBITORY ACTIVITY AGAINST PHOSPHOTRANSACETYLASE

PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING A MICROORGANISM INFECTION DISEASE COMPRISING A CHEMICAL COMPOUND WITH AN INHIBITORY ACTIVITY AGAINST PHOSPHOTRANSACETYLASE

机译:用于预防或治疗微生物感染疾病的药物组合物,所述化学组合物包含化学成分与抗磷脂酶的抑制活性

摘要

The present invention relates to a method for identifying ligand for phosphotransacetylase of Staphylococcus aureus using a virtual screening method and to a pharmaceutical composition for preventing or treating microorganism infectious diseases comprising the ligand as an active ingredient. The in silico virtual screening method of the present invention analyzes tertiary structure of target protein, and analyzes interactions between the target protein and reference ligand using a molecular dynamics simulation method, thereby predicting activity position of the target protein using homology modeling. Based on the above facts, the present invention identifies drug-like molecules having increased bond energy for the target protein and pharmacokinetics properties through docking analysis between the target protein and lead ligand library. The present invention identifies a compound represented by chemical formula I as a Staphylococcus aureus-derived phosphotransacetylase inhibitor using the above method. Therefore, the method of the present invention can rapidly and efficiently predict large amount of physiological active candidate substances based on proteomics, bio-informatics, and combinational chemistry, thereby being able to drastically reduce new drug development costs by being applied to a new drug development field.
机译:本发明涉及使用虚拟筛选方法鉴定金黄色葡萄球菌磷酸转乙酰酶的配体的方法,以及涉及以该配体为有效成分的预防或治疗微生物感染性疾病的药物组合物。本发明的计算机虚拟筛选方法分析靶蛋白的三级结构,并使用分子动力学模拟方法分析靶蛋白与参考配体之间的相互作用,从而使用同源性建模预测靶蛋白的活性位置。基于上述事实,本发明通过在靶蛋白和先导配体库之间的对接分析,鉴定了具有增加的与靶蛋白的键能和药代动力学性质的药物样分子。本发明使用上述方法将化学式I表示的化合物鉴定为金黄色葡萄球菌衍生的磷酸转乙酰酶抑制剂。因此,本发明的方法可以基于蛋白质组学,生物信息学和组合化学快速有效地预测大量的生理活性候选物质,从而能够通过应用于新药开发而大幅度降低新药开发成本。领域。

著录项

  • 公开/公告号KR20150005239A

    专利类型

  • 公开/公告日2015-01-14

    原文格式PDF

  • 申请/专利权人 INHA-INDUSTRY PARTNERSHIP INSTITUTE;

    申请/专利号KR20130078890

  • 发明设计人 KIM EUN KI;VIVEK KUMAR MORYA;

    申请日2013-07-05

  • 分类号G01N33/53;G01N33/68;A61K31/4196;A61P31/04;

  • 国家 KR

  • 入库时间 2022-08-21 15:00:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号